{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:28:36Z","timestamp":1789766916570,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.semnephrol.2014.04.004","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T20:30:09Z","timestamp":1398717009000},"page":"273-284","source":"Crossref","is-referenced-by-count":30,"title":["Role of Aldosterone Blockade in Resistant Hypertension"],"prefix":"10.1016","volume":"34","author":[{"given":"Brent M.","family":"Egan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiexiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2014.04.004_bib1","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988\u20132008","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jch.12057","article-title":"Clinical epidemiology of hypertension in the U.S. 1999\u20132010: Different definitions of prevalent hypertension impact the clinical epidemiology of hypertension and attainment of Healthy People goals","volume":"15","author":"Egan","year":"2013","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","article-title":"Uncontrolled and apparent treatment resistant hypertension in the U.S. 1988\u20132008","volume":"124","author":"Egan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCULATIONAHA.112.000500","article-title":"Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: a report from NHANES 1988\u20132010","volume":"128","author":"Egan","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.113.01448","article-title":"Prevalence of optimal treatment regimens in patients with apparent treatment resistant hypertension in a community-based practice network","volume":"62","author":"Egan","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jama.1988.03720020027031","article-title":"How common is white coat hypertension?","volume":"259","author":"Pickering","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring","volume":"57","author":"de la Sierra","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib9","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/archinte.168.21.2340","article-title":"Prognostic influence of office and ambulatory blood pressures in resistant hypertension","volume":"168","author":"Salles","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib10","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.amjhyper.2005.05.014","article-title":"Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension","volume":"18","author":"Pierdomenico","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11886-009-0060-6","article-title":"Role of ambulatory and home blood pressure recording in clinical practice","volume":"11","author":"Ghuman","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000215363.69793.bb","article-title":"Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure","volume":"47","author":"Mancia","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.mbp.0000200481.64787.c0","article-title":"Automated blood pressure measurement in routine clinical practice","volume":"11","author":"Myers","year":"2006","journal-title":"Blood Press Monitor"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/HJH.0b013e32831b9e6b","article-title":"Use of automated office blood pressure measurement to reduce the white coat response","volume":"27","author":"Myers","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib16","doi-asserted-by":"crossref","unstructured":"The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension. Blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol. 2011;27:415\u201333.","DOI":"10.1016\/j.cjca.2011.03.015"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0149-2918(98)80130-6","article-title":"Continuation of initial antihypertensive medication after 1 year of therapy","volume":"20","author":"Bloom","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib18","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1001\/jama.288.22.2868","article-title":"Interventions to enhance patient adherence to medication prescriptions","volume":"288","author":"McDonald","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/hr.2010.183","article-title":"Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy","volume":"34","author":"Ceral","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1751-7176.2012.00690.x","article-title":"Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension","volume":"14","author":"Irvin","year":"2012","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib21","first-page":"CD0011","article-title":"Interventions for enhancing medication adherence","volume":"2","author":"Haynes","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.2.6.757","article-title":"Can simple clinical measurements detect patient noncompliance?","volume":"2","author":"Haynes","year":"1980","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00005650-198110000-00008","article-title":"Screening for noncompliance among patients with hypertension: is self-report the best available measure?","volume":"19","author":"Inui","year":"1981","journal-title":"Med Care"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1185\/03007990802619425","article-title":"The Adherence Estimator: a brief proximal screener for patient propensity to adhere to prescription medications for chronic disease","volume":"25","author":"McHorney","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib25","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib26","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.112.194167","article-title":"Initial mono- and combination therapy and blood pressure control in the first year","volume":"59","author":"Egan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archinternmed.2011.1307","article-title":"A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans","volume":"172","author":"Ogedegbe","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jash.2013.06.004","article-title":"Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence","volume":"7","author":"Grigoryan","year":"2013","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/HYPERTENSIONAHA.109.133389","article-title":"Intensifying therapy for hypertension despite suboptimal adherence","volume":"54","author":"Rose","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib30","series-title":"Dominant role of the kidney in long-term regulation of arterial pressure and in hypertension. The integrated system for pressure control. In: Textbook of medical physiology","first-page":"216","author":"Guyton","year":"2006"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib31","series-title":"Frontiers in endocrinology","first-page":"249","article-title":"Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation, and hypertension","author":"Brody","year":"1980"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJM197204202861603","article-title":"Dependence of arterial pressure on intravascular volume in treated hypertensive patients","volume":"286","author":"Dustan","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00000441-198912000-00001","article-title":"Plasma volume in resistant hypertension: guide to pathophysiology and therapy","volume":"298","author":"Graves","year":"1989","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib34","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ajh.2011.171","article-title":"The plasma renin test reveals the contribution of body sodium-volume content and renin-angiotensin vasoconstriction to long term blood pressure","volume":"24","author":"Laragh","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib35","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib36","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1378\/chest.125.1.112","article-title":"Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea","volume":"125","author":"Calhoun","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib38","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/HYPERTENSIONAHA.110.154427","article-title":"Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension","volume":"56","author":"Friedman","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib39","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/jhh.2009.96","article-title":"Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report","volume":"24","author":"Gaddam","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1056\/NEJM200101113440204","article-title":"Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis","volume":"344","author":"Hanly","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/07435809809032689","article-title":"Aldosterone in obesity","volume":"24","author":"Goodfriend","year":"1998","journal-title":"Endocrine Res"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.semnephrol.2007.07.009","article-title":"The association of aldosterone with obesity-related hypertension and the metabolic syndrome","volume":"27","author":"Vogt","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.HYP.26.1.186","article-title":"Glucose metabolism in obese hypertensives and normotensives","volume":"26","author":"O\u05f3Shaughnessy","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/08037059309077526","article-title":"Therapy-resistant hypertension associated with central obesity, insulin resistance, and large muscle fibre area","volume":"2","author":"Isaksson","year":"1993","journal-title":"Blood Press"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.HYP.27.3.723","article-title":"Obesity hypertension is more closely related to impairment of insulin\u2019s fatty acid than glucose lowering action","volume":"27","author":"Egan","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/01.HYP.17.4.565","article-title":"Obesity, glucose intolerance, hyperinsulinemia, and response to antihypertensive drugs","volume":"17","author":"Modan","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib47","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1038\/oby.2006.277","article-title":"Why visceral fat is back: mechanisms of the metabolic syndrome","volume":"14","author":"Bergman","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.HYP.0000113294.06704.64","article-title":"Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MED.0b013e3283390fa4","article-title":"Aldosterone and cardiovascular disease","volume":"17","author":"Carey","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbagrm.2010.09.003","article-title":"Regulation of \u03b1ENaC expression by the circadian clock protein period 1 in mpkCCDc14 cells","volume":"1799","author":"Gumz","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11906-010-0175-6","article-title":"The kidneys and aldosterone\/mineralocorticoid receptor system in salt-sensitive hypertension","volume":"13","author":"Shibata","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib52","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension","volume":"150","author":"Sowers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tem.2012.09.004","article-title":"Aldosterone and cardiovascular disease: the heart of the matter","volume":"24","author":"He","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1524-6175.2007.06334.x","article-title":"Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension","volume":"9","author":"Calhoun","year":"2007","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib55","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000237742","article-title":"Predictors of hyperkalemia risk following hypertension control with aldosterone blockade","volume":"30","author":"Khosla","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib57","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/01.HYP.0000016176.16042.2F","article-title":"Resistant hypertension: comparing hemodynamic management to specialist care","volume":"39","author":"Taler","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.004_bib58","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ajh.2009.63","article-title":"Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial","volume":"22","author":"Egan","year":"2009","journal-title":"Am J Hypertension"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T15:26:01Z","timestamp":1538666761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929514000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0270929514000461"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2014.04.004","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}